Useful For: Aiding in the diagnosis of Chlamydia pneumoniae or Chlamydia psittaci infection.
Code | Name |
---|---|
RCLPNG | C. pneumoniae IgG |
RCLPNM | C. pneumoniae IgM |
RCLPSG | C. psittaci IgG |
RCLPSM | C. psittaci IgM |
Micro-Immunofluorescent Antibody (MIF)
Interpretation:
Chlamydia pneumoniae IgM:
<1:10 | IgM endpoint titers below 1:10 suggest that the patient does not have a current infection. These antibody levels may be found in patients with either no history of chlamydial infection or those with past infection whose antibody levels have dropped below detectable levels. |
≥1:10 | IgM endpoint titers of 1:10 or more are considered presumptive evidence of infection. |
Chlamydia pneumoniae IgG:
<1:64 | IgG endpoint titers below 1:64 suggest that the patient does not have a current infection. These antibody levels may be found in patients with either no history of chlamydial infection or those with past infection whose antibody levels have dropped below detectable levels. |
≥1:64 and <1:512 | A single specimen endpoint titer of 1:64 to 1:512 should be considered evidence of infection at an undetermined time. A second specimen collected 10 to 21 days after the original collection should be tested in parallel with the first. If the second specimen exhibits a titer 1:512 or more or a 4-fold increase over that of the initial specimen, current (acute) infection is indicated. Unchanging titers from 1:64 to 1:512 suggest past infection. |
≥1:512 | IgG endpoint titers of 1:512 or more are considered presumptive evidence of current infection. |
C pneumoniae antibody is detectable in 25% to 45% of adults tested.
Chlamydia psittaci IgM:
<1:10 | IgM endpoint titers below 1:10 suggest that the patient does not have a current infection. These antibody levels may be found in patients with either no history of chlamydial infection or those with past infection whose antibody levels have dropped below detectable levels. |
≥1:10 | IgM endpoint titers of 1:10 or more are considered presumptive evidence of infection. |
Chlamydia psittaci IgG:
<1:64 | IgG endpoint titers below 1:64 suggest that the patient does not have a current infection. These antibody levels may be found in patients with either no history of chlamydial infection or those with past infection whose antibody levels have dropped below detectable levels. |
≥1:64 | IgG endpoint titers of 1:64 or more are considered presumptive evidence of current infection. |
Cautions:
Antichlamydial IgG can persist for years. All results from chlamydial serologies must correlate with clinical history and other data available to the physician.
Specimens collected too early during primary infection may not contain detectable antibodies. If chlamydial infection is suspected, a second specimen should be collected 10 to 21 days later and tested in parallel with the original specimen.
During a primary Chlamydia infection, the early antibody response may be cross-reactive with multiple Chlamydia species.
This assay does not report antibodies detected against Chlamydia trachomatis. Sera from suspected cases of lymphogranuloma venereum (LGV) should be tested by a Lymphogranuloma Venereum Differentiation Antibody Panel. LGV testing is not performed by Mayo Clinic Laboratories. Due to the limited sensitivity and specificity of Chlamydia serologic tests, patients with suspected C trachomatis infection should be tested by a molecular method when clinical manifestations are present.
3 mL blood in RED TOP tube or GOLD SST
Outside Laboratories: Centrifuge sample and transfer serum to a separate plastic vial. Refrigerate serum.
Stability: Refrigerated (preferred): 30 days; Frozen: 30 days; Ambient: Unacceptable.
Reject Due To: Gross hemolysis, gross lipemia.
Centrifuge sample and transfer serum to a separate plastic vial. Refrigerate serum.
Sendouts:
Stability: Refrigerated (preferred): 30 days; Frozen: 30 days; Ambient: Unacceptable.
Reject Due To: Gross hemolysis, gross lipemia.
Sendout |
Mayo Clinic Laboratories (Superior Drive)
800-533-1710 3050 Superior Drive NW |
---|